Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.05 CAD | 0.00% | -28.57% | -54.55% |
07/06 | Numinus Wellness Comments on FDA Advisory Committee Meeting for Investigational MDMA-Assisted Therapy for PTSD | CI |
31/05 | Transcript : Numinus Wellness Inc. - Shareholder/Analyst Call |
End-of-day quotes
Sector Other Biotechnology & Medical Research
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
11.65M | - | - | - | |||
56.95B | - | |||||
40.26B | ||||||
39.32B | ||||||
28.37B | ||||||
26.45B |